Heart Failure in a Cohort of Patients with Chronic Kidney Disease: The GCKD Study

被引:19
|
作者
Beck, Hanna [1 ]
Titze, Stephanie I. [2 ]
Huebner, Silvia [2 ]
Busch, Martin [3 ]
Schlieper, Georg [4 ]
Schultheiss, Ulla T. [1 ]
Wanner, Christoph [5 ,6 ]
Kronenberg, Florian [7 ]
Krane, Vera [5 ,6 ]
Eckardt, Kai-Uwe [2 ]
Koettgen, Anna [1 ]
机构
[1] Univ Freiburg, Med Ctr, Div Nephrol, Dept Med, D-79106 Freiburg, Germany
[2] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany
[3] Univ Jena, Dept Internal Med 3, Jena, Germany
[4] Rhein Westfal TH Aachen, Fac Med, Div Nephrol & Clin Immunol, Aachen, Germany
[5] Univ Wurzburg, Div Nephrol, Dept Internal Med 1, Wurzburg, Germany
[6] Univ Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany
[7] Med Univ Innsbruck, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria
来源
PLOS ONE | 2015年 / 10卷 / 04期
关键词
CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; MEN BORN; EPIDEMIOLOGY; INSUFFICIENCY; POPULATION; DIAGNOSIS; DEATH; CLASSIFICATION; ASSOCIATION;
D O I
10.1371/journal.pone.0122552
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Aims Chronic kidney disease (CKD) is a risk factor for development and progression of heart failure (HF). CKD and HF share common risk factors, but few data exist on the prevalence, signs and symptoms as well as correlates of HF in populations with CKD of moderate severity. We therefore aimed to examine the prevalence and correlates of HF in the German Chronic Kidney Disease (GCKD) study, a large observational prospective study. Methods and Results We analyzed data from 5,015 GCKD patients aged 18-74 years with an estimated glomerular filtration rate (eGFR) of <60 ml/min/1.73m(2) or with an eGFR >= 60 and overt proteinuria (>500 mg/d). We evaluated a definition of HF based on the Gothenburg score, a clinical HF score used in epidemiological studies (Gothenburg HF), and self-reported HF. Factors associated with HF were identified using multivariable adjusted logistic regression. The prevalence of Gothenburg HF was 43% (ranging from 24% in those with eGFR >90 to 59% in those with eGFR<30 ml/min/1.73m2). The corresponding estimate for self-reported HF was 18% (range 5%-24%). Lower eGFR was significantly and independently associated with the Gothenburg definition of HF (p-trend <0.001). Additional significantly associated correlates included older age, female gender, higher BMI, hypertension, diabetes mellitus, valvular heart disease, anemia, sleep apnea, and lower educational status. Conclusions The burden of self-reported and Gothenburg HF among patients with CKD is high. The proportion of patients who meet the criteria for Gothenburg HF in a European cohort of patients with moderate CKD is more than twice as high as the prevalence of self-reported HF. However, because of the shared signs, symptoms and medications of HF and CKD, the Gothenburg score cannot be used to reliably define HF in CKD patients. Our results emphasize the need for early screening for HF in patients with CKD.
引用
下载
收藏
页数:15
相关论文
共 50 条
  • [41] Role of anemia in heart failure patients with chronic kidney disease
    Iordache, E. L. Elena Lelia
    Mihaila, M.
    Sinescu, C. J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 392 - 393
  • [42] Device Therapy in Heart Failure Patients With Chronic Kidney Disease
    Cannizzaro, Leon A.
    Piccini, Jonathan P.
    Patel, Uptal D.
    Hernandez, Adrian F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (09) : 889 - 896
  • [43] Congestive heart failure in patients with chronic kidney disease and on dialysis
    Schreiber, BD
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04): : 179 - 193
  • [44] Assessment and management of heart failure in patients with chronic kidney disease
    Andrea Igoren Guaricci
    Francesca Sturdà
    Roberto Russo
    Paolo Basile
    Andrea Baggiano
    Saima Mushtaq
    Laura Fusini
    Fabio Fazzari
    Fulvio Bertandino
    Francesco Monitillo
    Maria Cristina Carella
    Marco Simonini
    Gianluca Pontone
    Marco Matteo Ciccone
    Giuseppe Grandaliano
    Giuseppe Vezzoli
    Francesco Pesce
    Heart Failure Reviews, 2024, 29 : 379 - 394
  • [45] Assessment and management of heart failure in patients with chronic kidney disease
    Guaricci, Andrea Igoren
    Sturda, Francesca
    Russo, Roberto
    Basile, Paolo
    Baggiano, Andrea
    Mushtaq, Saima
    Fusini, Laura
    Fazzari, Fabio
    Bertandino, Fulvio
    Monitillo, Francesco
    Carella, Maria Cristina
    Simonini, Marco
    Pontone, Gianluca
    Ciccone, Marco Matteo
    Grandaliano, Giuseppe
    Vezzoli, Giuseppe
    Pesce, Francesco
    HEART FAILURE REVIEWS, 2024, 29 (02) : 379 - 394
  • [46] Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort
    Martin Busch
    Jennifer Nadal
    Matthias Schmid
    Katharina Paul
    Stephanie Titze
    Silvia Hübner
    Anna Köttgen
    Ulla T. Schultheiss
    Seema Baid-Agrawal
    Johan Lorenzen
    Georg Schlieper
    Claudia Sommerer
    Vera Krane
    Robert Hilge
    Jan T. Kielstein
    Florian Kronenberg
    Christoph Wanner
    Kai-Uwe Eckardt
    Gunter Wolf
    BMC Nephrology, 17
  • [47] Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study
    Schneider, Markus P.
    Schmid, Matthias
    Nadal, Jennifer
    Krane, Vera
    Saritas, Turgay
    Busch, Martin
    Schultheiss, Ulla T.
    Meiselbach, Heike
    Friedrich, Nele
    Floege, Juergen
    Nauck, Matthias
    Kronenberg, Florian
    Wanner, Christoph
    Eckardt, Kai-Uwe
    KIDNEY MEDICINE, 2023, 5 (11)
  • [48] Risk Factors for Congestive Heart Failure in Patients with Chronic Kidney Disease: the CRIC Study
    He, Jiang
    Yang, Wei
    Anderson, Amanda
    Dries, Daniel
    Feldman, Harold
    Kallem, RadhaKrishna
    Kanthety, Radhika
    Kusek, John
    Mazurick, Carissa
    Ojo, Akinlolu
    Raj, Dominic
    Rahman, Mahboob
    Ricardo, Ana
    Shlipak, Michael
    Soliman, Elsayed
    Wolf, Myles
    Hamm, Lee
    CIRCULATION, 2012, 126 (21)
  • [49] Prevalence and determinants of bone disease in patients with chronic heart failure - a prospective cohort study
    Verheyen, N. Nicolas
    Schmid, J.
    Kattnig, L.
    Bencic, D.
    Kolesnik, E.
    Manninger, M.
    Scherr, D.
    Fruhwald, F.
    Fuchsjaeger, M.
    Pieber, T.
    Obermayer-Pietsch, B.
    Fahrleitner-Pammer, A.
    Zirlik, A.
    Von Lewinski, D.
    Ablasser, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 188 - 188
  • [50] Daprodustat for anaemia in patients with heart failure and chronic kidney disease: A randomized controlled study
    Iso, Takashi
    Matsue, Yuya
    Mizukami, Akira
    Tokano, Takashi
    Isoda, Kikuo
    Suwa, Satoru
    Miyauchi, Katsumi
    Yanagisawa, Naotake
    Okumura, Yasuo
    Minamino, Tohru
    ESC HEART FAILURE, 2022, 9 (06): : 4291 - 4297